Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT02621645
PHASE4

TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence

Sponsor: Universitaire Ziekenhuizen KU Leuven

View on ClinicalTrials.gov

Summary

Multi-center open-label randomized controlled trial to assess if early intervention (12.0-14.0 weeks) (study group) improves the outcome of TRAP sequence as compared to late intervention (16.0-19.0 weeks) (control group). The investigators will randomly assign women diagnosed with TRAP sequence diagnosed between 12.0 and 13.6 weeks to an early or late intervention group (1:1), using a web-based application and a computer-generated list with random permuted blocks of sizes 2 or 4 (www.sealedenvelope.com), stratified by gestational age (GA) at inclusion (11.6 -12.6 weeks versus 13.0-13.6 weeks). Analysis will be by intention to treat.

Official title: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence: an Open-label Randomized Controlled Trial: TRAPIST - TRAP Intervention STudy

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

126

Start Date

2016-05

Completion Date

2025-06

Last Updated

2024-07-10

Healthy Volunteers

No

Interventions

PROCEDURE

Early selective reduction of TRAP mass

Ultrasound-guided intrafetal ablation using an 18 Gauge to 20 Gauge needle

PROCEDURE

Late selective reduction of TRAP mass

Ultrasound-guided intrafetal ablation using a 17 Gauge to 20 Gauge needle OR fetoscopic laser coagulation of the cord or anastomising vessels through a 17 Gauge to 7 French trocar, with a 1-1,3 mm fetoscope and a 400 µm laser fiber. The treating physician can decide which technique will be used for the selective reduction.

DEVICE

Ultrasound-guided intrafetal ablation using a 18 to 20 Gauge needle

DEVICE

Ultrasound-guided intrafetal ablation using a 17 to 20 Gauge needle

DEVICE

Laser coagulation of the cord or anastomising vessels through a 17 Gauge to 7 French trocar, with a 1-1,3 mm fetoscope and a 400 µm laser fiber

Locations (14)

Children's Memorial Hermann Hospital

Houston, Texas, United States

Universitätsklinik für Frauenheilkunde und Geburtshilfe

Graz, Austria

Universitaire Ziekenhuizen Leuven

Leuven, Belgium

Mount Sinai Hospital

Toronto, Canada

Centre Médico-Chirurgical et Obstétrical

Schiltigheim, France

Universitätsklinikum Hamburg-Eppendorf

Hamburg, Germany

Sheba Medical Center

Tel Litwinsky, Israel

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Milan, Italy

Ospedale dei Bambini Vittore Buzzi

Milan, Italy

Leiden University Medical Center

Leiden, Netherlands

Hospital Universitari Vall d'Hebron

Barcelona, Spain

Birmingham Women's Hospital

Birmingham, United Kingdom

King's College

London, United Kingdom

St. George's Hospital, University of London (UK sponsor)

London, United Kingdom